Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Q4 EBITDA Loss Widens To SEK 4.5 Mln

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    11/10/2023 07:06
    Oct 11 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * Q4 NET REVENUE WAS 2 827 (4 570) TKR
    * Q4 EBITDA WAS -4 468 (-3 626) TKR

Source text for Eikon:  ID: 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Newbury Pharmaceuticals AB

    See all news